NeOnc Technologies shares climb after Phase 2a brain-cancer trial results
NeOnc Technologies Holdings shares closed at $4.91, up 16.35% from a previous close of $4.22 on August 17, after Phase 2a results for its lead drug candidate circulated alongside several pieces of investor-relations content. Dollar volume was $1,716,903 across 3,469 trades. The